Established rheumatoid arthritis: clinical assessments

Best Practice and Research: Clinical Rheumatology

Volumn 21, Issue 5, 2007, Pages 807-825

  van Riel, Piet L C M ^b   Fransen, J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

clinical assessment; disease activity; outcome; rheumatoid arthritis

Indexed keywords

AMYLOID A PROTEIN; C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HLA DR ANTIGEN; HLA DR7 ANTIGEN; IMMUNOGLOBULIN M; RHEUMATOID FACTOR; STROMELYSIN;

ACUTE PHASE RESPONSE; ARTHRALGIA; CLINICAL ASSESSMENT; CLINICAL TRIAL; DISEASE ACTIVITY; DISEASE COURSE; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; JOINT DESTRUCTION; JOINT RADIOGRAPHY; JOINT SWELLING; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PHYSICAL DISABILITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REMISSION; REVIEW; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS; SCORING SYSTEM; SOCIOECONOMICS; TREATMENT PLANNING; VISUAL ANALOG SCALE;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; HUMANS; METHOTREXATE; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 34548538895     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2007.06.001     Document Type: Review

References (119)

1. Putte van de L.B.A., Gestel van A.M., and Riel van P.L.C.M. Early treatment of rheumatoid arthritis: rationale, evidence, and implications. Annals of the Rheumatic Diseases 57 (1999) 511-512
2. Quinn M.M., Conaghan P.G., and Emery P. The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence?. Rheumatology 40 (2001) 1211-1220
3. Riel van P.L.C.M., and Schumacher H.R. How does one assess early rheumatoid arthritis in daily clinical practice?. Best Practice and Research. Clinical Rheumatology 15 (2001) 67-76
4. Van Gestel A.M., and Stucki G. Evaluation of established rheumatoid arthritis. Best Practice and Research. Clinical Rheumatology 4 (1999) 629-644
5. Fries J.F. The hierarchy of outcome assessment. The Journal of Rheumatology 20 (1993) 546-547
6. Van der Heijde D.M.F.M., van Riel P.L.C.M., van Rijswijk M.H., et al. Influence of prognostic features on the final outcome in rheumatoid arthritis: a review of literature. Seminars in Arthritis and Rheumatism 17 (1988) 284-292
7. Emery P., Salmon M., Bradley H., et al. Genetically determined factors as predictors of radiological change in patients with early symmetrical arthritis. British Medical Journal 305 (1992) 1387-1389
8. Van der Heijde D.M.F.M., van Riel P.L.C.M., van Leeuwen M.A., et al. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients. British Journal of Rheumatology 31 (1992) 519-525
9. Visser H., Le Cessie S., Vos K., et al. How to diagnose rheumatoid arthritis early. A prediction model for persistent (erosive) arthritis. Arthritis and Rheumatism 46 2 (2002) 357-365
10. Combe B., Dougados M., Goupille P., et al. Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study. Arthritis and Rheumatism 44 (2001) 1736-1743
11. Kaltenhauser S., Wagner U., Schuster E., et al. Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity. The Journal of Rheumatology 28 (2001) 735-744
12. Listing J., Rau R., Muller B., et al. HLA-DRB1 genes, rheumatoid factor, and elevated C-reactive protein: independent risk factors of radiographic progression in early rheumatoid arthritis. Berlin Collaborating Rheumatological Study Group. The Journal of Rheumatology 27 (2000) 2100-2109
13. Uhlig T., Smedstad L.M., Vaglum P., et al. The course of rheumatoid arthritis and predictors of psychological, physical and radiographic outcome after 5 years of follow-up. Rheumatology 39 (2000) 732-741
14. Kroot E.J., de Jong B.A., van Leeuwen M.A., et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis and Rheumatism 43 (2000) 1831-1835
15. Schellekens G.A., Visser H., de Jong B.A., et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis and Rheumatism 43 (2000) 155-163
16. Paimela L., Palosuo T., Aho K., et al. Association of autoantibodies to filaggrin with an active disease in early rheumatoid arthritis. Annals of the Rheumatic Diseases 60 (2001) 32-35
17. Bas S., Perneger T.V., Mikhnevitch E., et al. Association of rheumatoid factors and anti-filaggrin antibodies with severity of erosions in rheumatoid arthritis. Rheumatology (Oxford) 39 (2000) 1082-1088
18. Van Jaarsveld C.H., ter Borg E.J., Jacobs J.W., et al. The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis. Clinical and Experimental Rheumatology 17 (1999) 689-697
19. Mattey D.L., Hassell A.B., Dawes P.T., et al. Independent association of rheumatoid factor and the HLA-DRB1 shared epitope with radiographic outcome in rheumatoid arthritis. Arthritis and Rheumatism 44 (2001) 1529-1533
20. El-Gabalawy H.S., Goldbach-Mansky R., Smith D., et al. Association of HLA alleles and clinical features in patients with synovitis of recent onset. Arthritis and Rheumatism 42 (1999) 1696-1705
21. Harrison B., Thomson W., Symmons D., et al. The influence of HLA-DRB1 alleles and rheumatoid factor on disease outcome in an inception cohort of patients with early inflammatory arthritis. Arthritis and Rheumatism 42 (1999) 2174-2183
22. Jantti J.K., Kaarela K., Luukkainen R.K., et al. Prediction of 20-year outcome at onset of seropositive rheumatoid arthritis. Clinical and Experimental Rheumatology 18 (2000) 387-390
23. Wolfe F., and Sharp J.T. Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression. Arthritis and Rheumatism 41 (1998) 1571-1582
24. Van der Heide A., Remme C.A., Hofman D.M., et al. Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthritis and Rheumatism 38 (1995) 1466-1474
25. Van Leeuwen M.A., van Rijswijk M.H., Sluiter W.J., et al. Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system. The Journal of Rheumatology 24 (1997) 20-27
26. Aman S., Paimela L., Leirisalo-Repo M., et al. Prediction of disease progression in early rheumatoid arthritis by ICTP, RF and CRP. A comparative 3-year follow-up study. Rheumatology (Oxford) 39 (2000) 1009-1013
27. Saevarsdottir S., Vikingsdottir T., Vikingsson A., et al. Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis. A prospective study. The Journal of Rheumatology 28 (2001) 728-734
28. Goldbach-Mansky R., Lee J., McCoy A., et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis and Research 2 (2000) 236-243
29. Glennas A., Kvien T.K., Andrup O., et al. Recent onset arthritis in the elderly: a 5 year longitudinal observational study. The Journal of Rheumatology 27 (2000) 101-108
30. Valenzuela-Castano A., Garcia-Lopez A., Perez-Vilches D., et al. The predictive value of the HLA shared epitope for severity of radiological joint damage in patients with rheumatoid arthritis. A 10 year observational prospective study. The Journal of Rheumatology 27 (2000) 571-574
31. Pease C.T., Bhakta B.B., Devlin J., et al. Does the age of onset of rheumatoid arthritis influence phenotype? A prospective study of outcome and prognostic factors. Rheumatology 38 (1999) 228-234
32. Fex E., Jonsson K., Johnson U., et al. Development of radiographic damage during the first 5-6 yr of rheumatoid arthritis. A prospective follow-up study of a Swedish cohort. British Journal of Rheumatology 35 (1996) 1106-1115
33. Curkovic B., Babic-Naglic D., Durrigl T., et al. The prognosis of rheumatoid arthritis. Reumatizam 43 (1996) 10-15
34. Kuiper S., van Gestel A.M., Swinkels H.L., et al. Influence of sex, age, and menopausal state on the course of early rheumatoid arthritis. The Journal of Rheumatology 28 (2001) 1809-1816
35. Van Lankveld W., Naring G., van't PadBosch P., et al. The negative effect of decreasing the level of activity in coping with pain in rheumatoid arthritis: an increase in psychological distress and disease impact. Journal of Behavioral Medicine 23 (2000) 377-391
36. Scharloo M., Kaptein A.A., Weinman J.A., et al. Predicting functional status in patients with rheumatoid arthritis. The Journal of Rheumatology 26 (1999) 1686-1693
37. Scharloo M., Kaptein A.A., Weinman J., et al. Illness perceptions, coping and functioning in patients with rheumatoid arthritis, chronic obstructive pulmonary disease and psoriasis. Journal of Psychosomatic Research 44 (1998) 573-585
38. Evers A.W., Kraaimaat F.W., Geenen R., et al. Psychosocial predictors of functional change in recently diagnosed rheumatoid arthritis patients. Behaviour Research and Therapy 36 (1998) 179-193
39. Persson L.O., Berglund K., and Sahlberg D. Psychological factors in chronic rheumatic diseases - a review. The case of rheumatoid arthritis, current research and some problems. Scandinavian Journal of Rheumatology 28 (1999) 137-144
40. Radanov B.P., Schwarz H.A., Frost S.A., et al. Relationship between self-rated functional status and psychosocial stress in patients suffering from rheumatoid arthritis. Psychotherapy and Psychosomatics 66 (1997) 252-257
41. Tugwell P., Boers M., and OMERACT Committee. Developing consensus on preliminary core efficacy endpoints for rheumatoid arthritis clinical trials. The Journal of Rheumatology 20 (1993) 555-561
42. Van Riel P.L.C.M. Provisional guidelines for measuring disease activity in RA clinical trials. Editorial. British Journal of Rheumatology 31 (1992) 793-794
43. Van Riel P.L.C.M., and van de Putte L.B.A. Clinical assessment and clinical trials in rheumatoid arthritis. Current Opinion In Rheumatology 6 (1994) 132-139
44. Felson D.T., Anderson J.J., Boers M., et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis and Rheumatism 36 (1993) 729-740
45. Anderson J.J., Wells G., Verhoeven A.C., et al. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis and Rheumatism 43 (2000) 22-29
46. Ward M.M. Assessing the relative sensitivity to change of rheumatoid arthritis activity measures: is the type of treatment an important third variable?. Journal of Clinical Epidemiology 49 (1996) 1161-1169
47. Prevoo M.L.L., van Riel P.L.C.M., van 't Hof M.A., et al. Validity and reliability of joint indices. A longitudinal study in patients with recent onset rheumatoid arthritis. British Journal of Rheumatology 32 (1993) 589-594
48. American College of Rheumatology Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Reduced joint counts in rheumatoid arthritis clinical trials. Editorial. Arthritis and Rheumatism 37 (1994) 463-464
49. Smolen J.S. Report on the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials. European Journal of Rheumatology 23 (1994) 37-39
50. Thompson P.W., and Kirwan J.R. Joint counts: a review of old and new articular indices of joint inflammation. British Journal of Rheumatology 34 (1995) 1003-1008
51. Smolen J.S., Breedveld F.C., Eberl G., et al. Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity. Arthritis and Rheumatism 38 (1995) 38-43
52. Prevoo M.L., Kuper I.H., van 't Hof M.A., et al. Validity and reproducibility of self-administered joint counts. A prospective longitudinal followup study in patients with rheumatoid arthritis. The Journal of Rheumatology 23 (1996) 841-845
53. Calvo F.A., Calvo A., Berrocal A., et al. Self-administered joint counts in rheumatoid arthritis: comparison with standard joint counts. The Journal of Rheumatology 26 (1999) 536-539
54. Wong A.L., Wong W.K., Harker J., et al. Patient self-report tender and swollen joint counts in early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists. The Journal of Rheumatology 26 (1999) 2551-2561
55. Hanly J.G., Mosher D., Sutton E., et al. Self-assessment of disease activity by patients with rheumatoid arthritis. The Journal of Rheumatology 23 (1996) 1531-1538
56. Stucki G., Liang M.H., Stucki S., et al. Self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity. Arthritis and Rheumatism 38 (1995) 795-798
57. Stucki G., Stucki S., Bruhlmann P., et al. Comparison of the validity and reliability of self-reported articular indices. British Journal of Rheumatology 34 (1995) 760-766
58. Scott D.L., and Houssien D.A. Joint assessment in rheumatoid arthritis. British Journal of Rheumatology 35 Suppl (1996) 214-218
59. Van der Heijde D.M.F.M., van 't Hof M.A., van Riel P.L.C.M., et al. Validity of single variables and indices to measure disease activity in rheumatoid arthritis. The Journal of Rheumatology 20 (1993) 538-541
60. Anderson J.J., and Chernoff M.C. Sensitivity to change of rheumatoid arthritis clinical trial outcome measures. The Journal of Rheumatology 20 (1993) 535-537
61. Astbury C., Platt R., Dixon J.S., et al. Optimizing the assessment of disease activity during treatment with anti-rheumatoid drugs. British Journal of Rheumatology 32 (1993) 467-473
62. Dixon J.S., Hayes S., Constable P.D.L., and Bird H.A. What are the 'best' measurements for monitoring patients during short-term second-line therapy?. British Journal of Rheumatology 27 (1988) 37-43
63. Van Leeuwen M.A., van Rijswijk M.H., van der Heijde D.M.F.M., et al. The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease. British Journal of Rheumatology 32 (1993) 9-13
64. Plant M.J., Williams A.L., O'Sullivan M.M., et al. Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis. Arthritis and Rheumatism 43 (2000) 1473-1477
65. Devlin J., Gough A., Huissoon A., et al. The acute phase and function in early rheumatoid arthritis. C-reactive protein levels correlate with functional outcome. The Journal of Rheumatology 24 (1997) 9-13
66. Van Leeuwen M.A., and van Rijswijk M.H. Acute phase proteins in the monitoring of inflammatory disorders. Baillière's Clinical Rheumatology 8 (1994) 531-552
67. O'Hara R., Murphy E.P., Whitehead A.S., et al. Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue. Arthritis Research 2 (2000) 142-144
68. Vallon R., Freuler F., Desta-Tsedu N., et al. Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases. Journal of Immunology 166 (2001) 2801-2807
69. Cunnane G., Grehan S., Geoghegan S., et al. Serum amyloid A in the assessment of early inflammatory arthritis. The Journal of Rheumatology 27 (2000) 58-63
70. Ribbens C., Andre B., Jaspar J.M., et al. Matrix metalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis. The Journal of Rheumatology 27 (2000) 888-893
71. Posthumus M.D., Limburg P.C., Westra J., et al. Serum matrix metalloproteinase 3 in early rheumatoid arthritis is correlated with disease activity and radiological progression. The Journal of Rheumatology 27 (2000) 2761-2768
72. Lacki J.K., Samborski W., Mackiewicz S., et al. Do changes in clinical improvement in rheumatoid arthritis patients treated with immunosuppressive drugs reflect the changes in acute phase proteins?. Upsala Journal of Medical Sciences 100 (1995) 233-242
73. Melzack R. The McGill pain questionnaire. Pain 1 (1975) 277-299
74. Meenan R.F., Gertman P.M., and Mason J.M. Measuring health status in arthritis: the arthritis impact measurement scales. Arthritis and Rheumatism 23 (1980) 146-152
75. Anderson K., Bradley L.A., McDaniel L.K., et al. The assessment of pain in rheumatoid arthritis: disease differentiation and temporal stability of a behavioral observation method. The Journal of Rheumatology 14 (1987) 700-704
76. Buchbinder R., Bombardier C., Yeung M., et al. Which outcome measures should be used in rheumatoid arthritis clinical trials? Clinical and quality-of-life measures' responsiveness to treatment in a randomized controlled trial. Arthritis and Rheumatism 38 (1995) 1568-1580
77. Bosi Ferraz M., Quaresma M.R., Aquino L.R.L., et al. Reliability of pain scales in the assessment of literate and illiterate patients in rheumatoid arthritis. The Journal of Rheumatology 17 (1990) 1022-1024
78. Felson D.T., Anderson J.J., Boers M., et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis and Rheumatism 38 (1995) 727-735
79. Bellamy N., Campbell J., and Syrotuik J. Comparative study of self-rating pain scales in rheumatoid arthritis patients. Current Medical Research and Opinion 15 (1999) 121-127
80. Verhoeven A.C., Boers M., and van der Linden S. Responsiveness of the core set, response criteria, and utilities in early rheumatoid arthritis. Annals of the Rheumatic Diseases 59 (2000) 966-974
81. Tugwell P., Wells G., Strand V., et al. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group. Arthritis and Rheumatism 43 (2000) 506-514
82. Lansbury A. A method for summation of the systemic indices of rheumatoid activity. American Journal of the Medical Sciences 232 (1956) 300-310
83. Fuchs H.A. The use of the disease activity score in the analysis of clinical trials in rheumatoid arthritis. The Journal of Rheumatology 20 (1993) 1863-1866
84. Prevoo M.L., van 't Hof M.A., Kuper H.H., et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis and Rheumatism 38 (1995) 44-48
85. Mallya R.K., and Mace B.E.W. The assessment of disease activity in rheumatoid arthritis using a multivariate analysis. Rheumatology and Rehabilitation 20 (1981) 14-17
86. Van Riel P.L.C.M., Reekers P., van de Putte L.B.A., et al. Association of HLA antigens, toxic reactions and therapeutic response to auranofin and aurothioglucose in patients with rheumatoid arthritis. Tissue Antigens 22 (1983) 194-199
87. Corkill M., Kirkham B.W., Chikanza I.C., et al. Intramuscular depot methylprednisolone induction of chrysotherapy in rheumatoid arthritis: a 24-week randomized controlled trial. British Journal of Rheumatology 29 (1990) 274-279
88. Davis M.J., Dawes P.T., Fowler P.D., et al. Comparison and evaluation of a disease activity index for use in patients with rheumatoid arthritis. British Journal of Rheumatology 29 (1990) 111-115
89. Symmons D.P., Hassell A.B., Gunatillaka K.A., et al. Development and preliminary assessment of a simple measure of overall status in rheumatoid arthritis (OSRA) for routine clinical use. The Quarterly Journal of Medicine 88 (1995) 429-437
90. Birrell F.N., Hassell A.B., Jones P.W., et al. Why not use OSRA? A comparison of Overall Status in Rheumatoid Arthritis (RA) with ACR core set and other indices of disease activity in RA. The Journal of Rheumatology 25 (1998) 1709-1715
91. Smolen J., Breedveld F.C., Schiff M., et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 42 2 (2003) 244-257
92. Fransen J., Hauselmann H., Michel B.A., et al. Responsiveness of the self-assessed rheumatoid arthritis disease activity index to a flare of disease activity. Arthritis and Rheumatism 44 (2001) 53-60
93. Fransen J., Langenegger T., Michel B.A., et al. Feasibility and validity of the RADAI, a self-administered rheumatoid arthritis disease activity index. Rheumatology (Oxford) 39 (2000) 321-327
94. Pinals R.S., Masi A.T., and Larsen R.A. Preliminary criteria for remission in rheumatoid arthritis. Arthritis and Rheumatism 24 (1981) 1308-1315
95. Smythe H.A., Helewa A., and Goldsmith C.H. 'Independent assessor' and 'pooled index' as techniques for measuring treatment effects in rheumatoid arthritis. The Journal of Rheumatology 4 (1977) 144-152
96. Paulus H.E., Egger M.J., Ward J.R., et al. Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. Arthritis and Rheumatism 33 (1990) 477-484
97. Van Gestel A.M., Prevoo M.L.L., van't Hof M.A., et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Arthritis and Rheumatism 39 (1996) 34-40
98. Scott D.L. A simple index to assess disease activity in RA. The Journal of Rheumatology 20 (1993) 582-584
99. Villaverde V., Balsa A., Cantalejo M., et al. Activity indices in rheumatoid arthritis. The Journal of Rheumatology 27 (2000) 2576-2581
100. Van Gestel A.M., Anderson J.J., van Riel P.L., et al. ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology. The Journal of Rheumatology 26 (1999) 705-711
101. Felson D.T., Anderson J.J., Lange M.L., et al. Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent?. Arthritis and Rheumatism 41 (1998) 1564-1570
102. Prevoo M.L.L., Gestel van A.M., van 't Hof M.A., et al. Remission in a prospective study of patients with rheumatoid arthritis. ARA preliminary remission criteria in relation to the disease activity score. British Journal of Rheumatology 35 (1996) 1101-1105
103. Svensson B., Schaufelberger C., Teleman A., et al. Remission and response to early treatment of RA assessed by the Disease Activity Score. BARFOT study group. Better Anti-rheumatic Farmacotherapy. Rheumatology (Oxford) 39 (2000) 1031-1036
104. Fransen J., Creemers M.C.W., and Van Riel P.L.C.M. Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology (Oxford) 43 10 (2004 Oct) 1252-1255
105. Van Riel P.L.C.M., and Fransen J. To be in remission or not: is that the question?. Annals of the Rheumatic Diseases 64 10 (2005 Oct) 1389-1390
106. Pham B., Cranney A., Boers M., et al. Validity of area-under-the-curve analysis to summarize effect in rheumatoid arthritis clinical trials. The Journal of Rheumatology 26 (1999) 712-716
107. Bathon J.M., Martin R.W., Fleischmann R.M., et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. The New England Journal of Medicine 30 343 (2000) 1586-1593
108. Van Riel P.L., and van Gestel A.M. Area under the curve for the American College of Rheumatology improvement criteria: a valid addition to existing criteria in rheumatoid arthritis?. Arthritis and Rheumatism 44 (2001) 1719-1721 (letter)
109. Twisk J.W. Different statistical models to analyze epidemiological observational longitudinal data: an example from the Amsterdam Growth and Health Study. International Journal of Sports Medicine 18 Suppl 3 (1997) S216-S224
110. Welsing P.M.J., Landewe R.B., Van Riel P.L., et al. The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis. Arthritis and Rheumatism 50 (2004) 2082-2093
111. Rasker J.J., and Cosh J.A. Course and prognosis of early rheumatoid arthritis. Scandinavian Journal of Rheumatology 79 Suppl (1989) 45-56
112. Welsing P.M.J., van Gestel A.M., Swinkel H.L., et al. The relation between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis and Rheumatism 44 (2001) 2009-2017
113. Wolfe F., Hawley J., and Cathey M.A. Clinical and Health Status measures over time: Prognosis and outcome assessment in rheumatoid Arthritis. The Journal of Rheumatology 18 (1991) 1290-1297
114. Wolfe F., and Pincus T. The level of inflammation in rheumatoid arthritis is determined early and remains stable over the longterm course. The Journal of Rheumatology 28 (2001) 1817-1824
115. Welsing P.M.J., Fransen J., and Riel van P.L.C.M. Is the disease course of Rheumatoid Arthritis Becoming Milder? Time Trends Since 1985 in an Inception Cohort of Early Rheumatoid Arthritis. Arthritis and Rheumatism 52 9 (2005) 2616-2624
116. Pincus T., Sokka T., and Kautiainen H. Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985. Arthritis and Rheumatism 52 4 (2005 Apr) 1009-1019
117. Kremers H.M., Nicola P., Crowson C.S., et al. Therapeutic strategies in rheumatoid arthritis over a 40-year period. The Journal of Rheumatology 31 12 (2004) 2366-2373
118. Wiles D.G., Scott D.G.I., Barret E.M., et al. Benchmarking: the five year outcome of rheumatoid arthritis assessed using a pain score, the Health Assessment Questionnaire, and the short form-36 (SF-36) in a community and a clinic based sample. Annals of the Rheumatic Diseases 60 (2001) 956-961
119. Van Zeben D., Hazes J.M., Zwinderman A.H., et al. The severity of rheumatoid arthritis: a 6-year followup study of younger women with symptoms of recent onset. The Journal of Rheumatology 21 (1994) 1620-1625